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Abstract 
The objective of this study was to estimate accuracy of genomic prediction for disease 
resistance to viral nervous necrosis and vibriosis using sparse and genome sequence SNP-
data in Atlantic cod. The disease challenge test data of viral nervous necrosis and vibriosis 
used in this study were obtained from the National Atlantic cod breeding program which is 
running in Tromsø, Norway and we used disease challenge test data of year-class 2009 for 
both traits. Disease resistance for both traits was measured as survival at a fixed point in time 
and assessed as a binary variable. We obtained the result of challenge test data of 707 and 
728 individuals for viral nervous necrosis and vibriosis respectively. The individuals came 
from75 full-sib and half-sib families for both diseases and the number of individuals per 
family varied from 7 to 20 (average of 9.7) in viral nervous necrosis, and 6 to 10 in vibriosis. 
On top of pedigree information of 1,743 individuals, three genotype data sets were used in 
this study, and based on these data sets three different genomic relation matrices were 
calculated. These were SPARSE8 (genotype data of 283 SNP markers at chromosome 8 of 
1,743 individuals), SPARSE GENOME (1,577 individuals’ genotype data of 8,658 SNP 
markers across the entire genome) and DENSE8 (imputed high density genotypes (759,270 
SNPs) of chromosome 8 of 1,743 individuals). The genomic relation matrices were used in 
the GBLUP with polygenic models to estimate the variance components which were 
explained by the genomic information, and the genomic estimated breeding values using 
ASReml software. Fivefold within-family cross validations were carried out by randomly 
masking 20% of phenotypic records within each family in order to evaluate the accuracy of 
prediction for the viral nervous necrosis disease trait. Each observation was masked once and 
141 phenotypes were masked in the first, second and third cross validation tests, whereas 142 
phenotypes were masked in the fourth and fifth cross validation tests. Finally, the phenotypic 
values of the masked individuals were predicted based on the 566 or 565 phenotypic 
observations of the unmasked individuals. In the case of a between- families cross validation 
test, the phenotypic values of 20% of the families were masked at a time and their phenotypic 
values were predicted from the other families’ phenotypic values. A total of 15 families were 
masked in each cross validation and the total masked phenotypes were 140, 142, 136, 137 
and 153 in the first, second, third, fourth and fifth cross validations respectively. The 
accuracy of prediction was calculated based on the correlation between the predicted 
phenotypic values and observed phenotypic values. The results of analysis showed that for 
the trait disease resistance to viral nervous necrosis, heritability estimates of the trait using 
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the traditional BLUP (h2= 0.359) and GBLUP (SPARSE8) (h2= 0.355) were almost equal. 
However, GBLUP (DENSE8) (h2= 0.335) and SPARSE GENOME (h2= 0.371) had the 
lowest and the highest heritability estimates respectively, but these differences were not 
significant according to their log- likelihood estimates. In the case of vibriosis, our data were 
not able to distinguish between the genetic variation explained by the genomic information 
and the pedigree information. The SPARSE GENOME gave a 0.117 heritability estimate by 
fixing the variance explained by pedigree information at the boundary 0. According to a 
within-family cross validation test for viral nervous necrosis, the accuracies were estimated 
as 0.329 in the case of the traditional BLUP and GBLUP (DENSE8) models, but 0.336 in the 
SPARSE GENOME model. In addition to this, results of between-family cross validation 
showed that the accuracy of prediction of the DENSE8 (0.15) was less than that of the 
SPARSE8 (0.16). In our study we found a high heritability of resistance to viral nervous 
necrosis in Atlantic cod in all models. However, our heritability estimate was lower than the 
extremely high estimates of other studies in Atlantic cod. The total number of fish, the 
average number of fish per family, and the model we used in our study could be possible 
reasons for our relatively lower estimate of heritability for disease resistance to viral nervous 
necrosis. In our study, the accuracy of prediction of the genomic estimated breeding values 
using the sparse SNP markers (SPARSE GENOME) did not show a big difference compared 
with the traditional estimated breeding values, and this could be due to the fact that the 
phenotypical and genotypical data we used for training was too small to accurately capture 
the whole fraction of the variance explained by the SNP chip. Moreover, the accuracy of 
prediction of imputed high density genotypes (DENSE8) of chromosome 8 for disease 
resistance for viral nervous necrosis was not better than that of SPARSE 8, and this could be 
because in within- family genomic selection, big segments are inherited together and so the 
sparse SNPs could be sufficient to detect the chromosome segments. The low heritability 
estimate of our study to the trait disease resistance for vibriosis is consistent across all 
studies. However, the accuracy of genomic prediction could not be assessed by cross-
validation, since we were not able to distinguish the genetic variance explained by the 
genomic and pedigree information. In conclusion, for both traits more phenotypic and 
genotypic data are required in order to properly evaluate the accuracy of prediction of the 
genomic information. 
Keywords: Accuracy of prediction /Atlantic cod/disease resistance/SNP/ viral nervous necrosis 
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1. Introduction 
Fish diseases are major limiting factors facing the Norwegian fish farming industry today 
(Nakai et al., 2009, Woo et al., 2011).Vaccination, drug therapy, hygiene and eradication of 
infected population are the current strategies to control infectious diseases (Woo et al., 2011). 
Therefore, the role of on-going research and implementation of appropriate disease control 
strategies are critically important to the fish farming industry (Woo et al., 2011). A variety 
bacterial, viral and parasitic caused diseases are known on farmed and wild cod (Woo et al., 
2011). Vibriosis is the most important bacterial disease in farmed Atlantic cod in Norway and 
it is causing singinificant mortalities and economic losses (Johansen et al., 2011). Viral 
nervous necrosis (VNN) is a viral disease caused by Nodavirus (Nakai et al., 2009). The virus 
infects more than 30 fish species and is causing mass mortality in aquaculture hatcheries 
worldwide (Korsnes, 2008, Yang et al., 2012). Fish which are infected by the virus show 
abnormal swimming, dark coloration and anorexia as clinical signs, and in severe outbreaks 
the mortality rate can exceed 95% (Ransangan and Manin, 2010, Yang et al., 2012). The 
virus also infects Atlantic cod (Gadus morhua) and causes economic losses. Disease 
outbreaks due to VNN have been reported in juvenile and adult farmed Atlantic cod in 
Norway (Hellberg et al., 2010). 
 
Disease control or management using host genetic resistance is increasingly recognized as a 
key component of effective disease control, complementing or sometimes replacing existing 
strategies (Daetwyler et al., 2008). This is further supported by the significant genetic 
variation in disease resistance reported in different fish species (Chevassus and Dorson, 
1990). The traditional breeding methods have been effective in selecting for animals with 
easy-to-measure production traits in the absence of molecular knowledge of the genes acting 
on quantitative trait loci (Goddard and Hayes, 2009b). However, the efficiency of these 
traditional methods decrease when traits are measured in one sex, after death or late in life, or 
if measuring the trait is expensive and difficult (Goddard and Hayes, 2009b, Eggen, 2012). 
Disease resistance is a difficult trait to improve using the traditional selection method and 
often shows a dichotomous distribution of phenotypes (diseased or non- diseased). Resistance 
against specific diseases affecting aquaculture species show moderate to high heritability 
when tested in artificial challenge tests (Ødegård et al., 2011, Fjalestad et al., 1993) . In 
artificial challenge test, fish are exposed to one specific pathogen at a time in a controlled 
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environment and mortalities are recorded on a daily basis or in some cases more frequently. 
The test is continued until at least 50% of the fish have died or until mortality of the fish 
stops rising (Fjalestad et al., 1993) . Although the method improves the heritability estimate 
to disease resistance, fish that have been challenge-tested for disease resistance cannot be 
used as breeding stock. As a result of this, selection for diseases resistance is based on a 
performance test of siblings of the candidates. However, in case of the traditional aquaculture 
breeding schemes, with a sib test, only 50% of the total genetic variance of the candidates is 
exploited, perhaps less (Nirea et al., 2012). In conclusion, the traditional breeding methods 
with a sib test using artificial challenge test do not capture the majority of the genetic 
variance to disease resistance and are therefore not very efficient to genetically improve 
disease resistance. 
In order to exploit the full benefit of the genotypic information from whole genomes in the 
genetic evaluation of animals, Meuwissen et al. (2001) proposed the genomic selection (GS) 
method. It is a selection method, which simultaneously uses high density markers that cover 
the whole genome to predict the breeding values of selection (Meuwissen et al., 2001). The 
method assumes that every QTL (large or small) affecting the trait of interest can be 
explained by several nearby markers, which together explain all the genetic variation caused 
by QTL. Implementation of genomic selection involves estimation of the effect of 
chromosome segments/SNP markers in a reference population and prediction of genomic 
estimated breeding values for selection candidates not in the reference population. So, in 
order to implement genomic selection, a phenotyped and genotyped reference population for 
large sets of markers should be available (Goddard and Hayes, 2009b). The reference 
population is used to develop the prediction equation for the estimation of genomic breeding 
values in non-phenotyped individuals (selection candidates) based on their genotype alone. 
Therefore, genomic selection could overcome the shortcoming of the traditional selection 
methods and marker assisted selection and it can predict breeding values more accurately 
(Meuwissen et al., 2001, Zhang et al., 2011). 
Genomic selection in aquaculture industry can be used to solve the main drawbacks of 
traditional selection which are lack of pedigree recording and the large increase in inbreeding 
(Gjedrem and Gjøen, 1995, Nielsen et al., 2009). It has been studied using computer 
simulations and all the simulation studies showed that genomic selection can be used in 
aquaculture to use both within- and between-family variation during selection for both 
continuous and dichotomous (disease resistance) traits to increase the accuracy of selection 
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(Nielsen et al., 2009, Sonesson and Meuwissen, 2009). Simulation studies with the 
assumptions of high density genotyping and a large number of fish showed that genomic 
selection could increase accuracy of selection and genetic gain in aquaculture species 
particularly for traits measured on sibs of the selection candidates (Nielsen et al., 2009). 
Another simulation study to extend the Bayes B method of genome wide evaluation 
(Meuwissen et al., 2001) to include dichotomous traits indicated that the accuracy of genome 
wide evaluation for disease resistance in aquaculture sib based programs is increased by 16% 
compared with the linear model, in the case of low heritability and disease prevalence 
(Villanueva et al., 2011). Despite of the simulation findings, the actual applications of 
genomic selection in fish are few. Lack of dense marker maps and high- throughput SNP 
arrays are the constraint (Nielsen et al., 2009, Sonesson and Meuwissen, 2009). Therefore, 
the contribution of currently developed high–density (~130 K) SNP genotyping array of 
Atlantic salmon has significant contribution to the practical application of genomic selection 
in aquaculture breeding programs (Houston et al., 2014). 
In aquaculture breeding, full implementation of genomic selection is more expensive. This is 
due to the large number of selection candidates and test individuals required to genotype, and 
low economic value of each selected individual (Ibañez-Escriche and Gonzalez-Recio, 2011). 
Then, the cost of genotyping is one of the limitations for the implementation of genomic 
selection in aquaculture breeding programs. Within- family genomic selection is one option 
for low marker density genomic selection strategies to keep the cost of genotyping low 
(Lillehammer et al., 2013). The method is a combination of genomic within-family breeding 
values, based on low density genotyping and conventional BLUP between family breeding 
values. Another alternative using the central idea of low density SNP panels is proposed by 
Goddard and Hayes (2009a), where the key ancestors are genotyped with dense panels or 
with whole-genome re-sequencing and the selection candidates are genotyped with standard 
low-density panels. Then, the chromosome segments in the selection candidates are traced 
back to the key ancestors and their genotypes are inferred at all markers assayed on the key 
ancestors. This method is known as imputation (Mulder et al., 2012). It is a method of 
exploiting linkage disequilibrium and/or linkage analysis by deducing a higher density 
genotype from a lower density genotype and which results in reduced genotyping costs. In 
Holstein-Friesian dairy cattle, an average accuracy of imputation from 2,909 SNPs to 54,001 
SNPs of 0.98 was reported (VanRaden et al., 2011). So, lower density genotyping together 
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with imputation can be used to reduce the cost of genomic selection (van Marle-Köster et al., 
2013).  
The objective of this study was to estimate accuracy of genomic prediction for disease 
resistance to viral nervous necrosis and vibriosis using sparse and genome sequence SNP-
data in Atlantic cod. 
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2. Literature review 
2.1. The principle of genomic selection  
Genomic selection is defined as a selection decision based on genomic breeding values. The 
method simultaneously uses high density markers that cover the whole genome to predict the 
breeding values of selection candidates (Meuwissen et al., 2001). It assumes that every QTL 
(large or small) affecting the trait of interest can be explained by several nearby markers, 
which together explain all the genetic variation caused by QTL due to at least one of the 
markers being in linkage disequilibrium with each gene or QTL affecting the trait of interest. 
As a result of this, theoretically, it is possible to capture all genetic variance by markers if the 
marker density is high enough (Zhang et al., 2011, Meuwissen et al., 2001). 
2.2. Steps in genomic selection 
Getting a large group of animals with accurate phenotypes for the trait(s) of interest is the 
first step in the genomic selection process. This large group of animals is called a reference 
population or training animals (Meuwissen, 2007, Goddard and Hayes, 2009b). The reference 
population also needs to be genotyped. Using both the genotypic and phenotypic information 
of the reference population, a prediction equation will be developed that predicts the breeding 
value from the SNP genotypes (Goddard and Hayes, 2009b). Then, the genomic breeding 
value of candidate animals can be calculated using the prediction equation, based on their 
genotypes from the SNP array without any accurate phenotypes for these animals. Finally, 
the candidate animals are ranked on the estimated genomic breeding values, and the best 
candidate animals are selected to breed the next generation (Goddard and Hayes, 2009b, 
Eggen, 2012). 
2.3. Methodologies for genomic selection 
Estimating the effect of each SNP on the trait is the main challenge in genomic prediction, 
since, the number of SNPs is much larger than the number of phenotypes available (Goddard 
and Hayes, 2009b). Several statistical methodologies have been developed to address this 
problem by using prior information about the distribution of the SNP effects. The 
methodologies can be grouped in two based on their assumptions about the SNP effects. 
GBLUP, BayesA and Bayesian LASSO assume all SNPs have effects but with different prior 
information. However, the second group such as BayesB, and BayesC take the assumption 
that many SNPs have no effect (de los Campos et al., 2013). On top of the assumption on the 
SNPs effect, they also have an assumption on the distribution of SNPs effects. GBLUP 
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assumes the SNP effects are normally distributed (Meuwissen et al., 2001). BayesA and 
BayesB both assume SNP effects have a student`s t-distribution but some SNPs are assumed 
to have no effect in the case of BayesB (de los Campos et al., 2013, Meuwissen et al., 2001). 
Bayesian LASSO assumes that SNP effects have an exponential distribution. (Hayes et al., 
2013, Park and Casella, 2008). 
 
2.4. The accuracy of genomic estimated breeding value 
The correlation between the GEBVs and true breeding values is called accuracy (r) of 
genomic estimated breeding value (Meuwissen et al., 2001). Unlike simulation studies, true 
breeding values are unknown in a real population. Daetwyler et al. (2008) derived the first 
formula that predict the accuracy of genomic estimated breeding values and it was derived as  
  = (ℎ/(ℎ + )) (1) 
where Np is the total number of phenotypic records in the reference population, ℎ is the 
heritability of the trait investigated, and Nqtl is the number of independent QTLs affecting the 
trait. A different form of the formula was derived by Goddard (2009) as.  
  = 1 − /(2√) log 1 +  + 2√1 +  − 2√ (2) 
where a = 1+2/Np, = (1-h2) Me/ (h2log (2Ne)) in which Ne is the effective population size 
in historical population, and Me is the effective number of chromosome segments estimated 
from Me = (2NeL)/log (4NeL), where L is the length of the genome. After derivation of the 
above formula (2) Daetwyler et al. (2010) included Me into the previous formula (1). They 
deduced that Nqtl has an influence on the BayesB method but not on GBLUP, so based on this 
conclusion they derived two formulas.  
 
In the case of GBLUP,  
  = √ ℎ/( ℎ + ) (3) 
Whereas in the case of BayesB method, 
  = √ ℎ/( ℎ + min", $) (4) 
Deviations between the observed and predicted accuracies can be due to the violation of the 
different assumptions made while the formulas were derived. In general both predicted and 
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observed accuracies respond in similar ways to change in the relevant parameters (Zhang et 
al., 2011). 
 
2.5. Statistical analysis of disease- related traits 
Cross–sectional and longitudinal models are the most common models which are used to 
analyse disease related traits (Noordhuizen et al., 2001). Cross-sectional models are the 
simplest statistical models used for analyzing challenge test data and in these models, disease 
resistance is measured as a single record ( e.g., alive or dead) at a specific point in time 
(Ødegård et al., 2011). The cross-sectional studies therefore take a snapshot of the situation at 
a specific moment but time of death is not taken into account (Thrusfield, 2013) . In the case 
of binary outcome variables, the residuals do not have normal distribution, which results in 
the violation of the assumption of linear regression (Noordhuizen et al., 2001, Thrusfield, 
2013). Therefore, generalized linear mixed models which account for the binary nature of the 
data are the appropriate type of model to analyse the nature of such binary data, using the 
probit link function (Threshold model) (Thrusfield, 2013) . However, as Ødegård et al (2011) 
reviewed most of studies found limited differences between the linear models and threshold 
models with respect to accuracy of predicted breeding value. Further, they added that, if the 
heritability and the family size increases, the relative difference is expected to decrease. They 
also noticed that studies which used a plain binary expression of alive or dead did not capture 
the full extent of the disease resistance as well as those studies which used a longitudinal 
measure of time until death (for example, the first fish to die are the least resistance ones). In 
such a follow up study, the exact survival time is only known for those individuals that show 
the event (dead) while only the minimum survival time is known for the survivors (Ødegård 
et al., 2011). Moreover, the effect of environmental factors may not be constant over time 
and this usually causes the survival time to not be normally distributed. Proportional hazard 
models or survival score, which approximates proportional hazard models have been 
suggested for analysis of life time data (Ødegård et al., 2011). So, the types of model we use 
could vary depending on the data we have and the situation we want to study. 
  
2.6. Nervous necrosis virus 
Nodavirus or nervous necrosis virus is an emerging pathogen, which belongs to the viral 
family Nodaviridae (Samuelsen et al., 2006). The Nodavirus causes the diseases commonly 
known as viral nervous necrosis (VNN) or viral encephalopathy and retinopathy (VER) in 
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marine fish farming worldwide (Korsnes, 2008, Samuelsen et al., 2006). Although these 
viruses can affect older market size fish, it mainly affects a younger stage of fish and 
damages the central nervous system in susceptible fish species. Infected fish show abnormal 
swimming behavior, abnormal posture and muscle tremors (Chi et al., 2005).  
 
2.6.1. Transmission of the virus 
Horizontal and vertical transmission of VNN has been reported in several research findings 
(Korsnes, 2008, Hellberg et al., 2010). Vertical transmission can occur as transovum 
transmission where the pathogen is present on the egg surface, and the other way if the 
pathogen only is present inside the egg (transovarian) (Korsnes, 2008, Fraser, 1986). The 
horizontal transmission occurs through influent and rearing water, and via utensils, vehicles, 
and human activity (Nakai et al., 2009) 
 
2.6.2. Diagnosis of the virus 
Establishment of specific and sensitive methods for nodavirus detection are important, both 
as diagnostic tools and for scientific studies of the virus (Dalla Valle et al., 2000). Tentative 
diagnosis of VNN is based on the appearance of vacuoles in the brain, spinal cord, and/or 
retina as seen by light microscopy (Hellberg et al., 2010). However, individual fish showing 
only a few vacuoles in the nervous tissues pose a difficulty in diagnosis (Nakai et al., 2009). 
In general, the most commonly confirmatory diagnosis methods used could be divided into 
molecular, immunological and cell culture (Korsnes, 2008, Dalla Valle et al., 2000). The 
immunologically based assays could be subdivided into direct and indirect detection of virus 
particles, and included enzyme-linked immunosorbent assay (ELISA), indirect fluorescent 
antibody technique (IFAT) and later immunohistochemistry (IHC) and neutralization tests 
(Korsnes, 2008). The most widely used immunological methods for diagnosing VNN have 
been ELISA and IHC (Breuil and Romestand, 1999). RT-PCR and realtime RT-PCR assays 
are molecular methods for the detection of VNN and have played an even more important 
role in detecting and characterizing viruses (Muroga, 1994). 
 
2.6.3. Control of VNN 
Korsnes (2008) suggested strategies for controlling VNN in farming of fish, and the strategies 
involve screening of fish for the disease and development of a vaccine. This resulted in the 
reduction of the risk of introduction and spread the virus in farmed populations of fish by 
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blocking both vertical and horizontal transmission routes (Nakai et al., 2009). Screening and 
monitoring of health status of fish in order to identify infected (carrier) fish and keep the 
brood stock in a sheltered aquaculture system to prevent horizontal transmission of VNN are 
strategies which help to have VNN-free brood (Muroga, 1994, Hellberg et al., 2010). 
Avoiding immunosuppression and subsequent increased chance of infection with the virus 
are key control strategies in an open system such as marine growth site, where fish are kept in 
cages at higher density and sources of virus might be other farmed fish at the site or wild 
stocks of fish in the vicinity (Fraser, 1986). Ødegård et al. (2010) have reported high 
heritability (0.75 in case of threshold mixed model and 0.43 using linear mixed model) for 
disease resistance to VNN using challenge test in Atlantic cod. So, in addition to the above 
control strategies, selective breeding of fish for VNN resistance is one alternative to control 
and prevent the disease in fish farming industry.  
 
2.7. Vibriosis 
Vibriosis is one of the most prevalent fish disease caused by a gram negative bacteria 
belonging to the genus Vibrio and it is commonly found in the aquatic environment, the 
majority of which are non-pathogenic (Actis et al., 2011). Vibrio anguillarum, Vibrio 
salmonicida and Vibrio ordalii are the species which cause the most economically serious 
disease (Gratacap, 2008). 
 
2.7.1. Transmission of Vibriosis 
The interaction of the host-pathogen-environment trigger the occurrence of vibriosis 
outbreak, and the main predisposing factor is the stress level of the fish (Gratacap, 2008). 
Increase in temperatures has a known effect on the stress level of fish which result in disease 
outbreaks (Buller, 2004). Transport and transfer from freshwater to seawater and pollution 
can also increase the rate of vibriosis, on top this, sometimes vaccination of Atlantic cod can 
be followed by outbreaks (Gratacap, 2008). The mode of transmission of the bacterium is 
through water, with fish carriers or contaminated fish farm equipment and it can enter 
through skin, fins, gills and anus (Buller, 2004). The clinical sign of the disease are 
haemorrhage to intestines, spleen, muscle, body cavity and darkened coloration to skin and 
fins. In addition to this, changes to the eyes in size as well as color and grey or white lesion 
on intestines and spleen are also clinical sign of the disease (Actis et al., 2011, Beacham and 
Evelyn, 1992). 
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2.7.2. Diagnosis of vibriosis 
In the case of vibriosis there is no reliable presumptive diagnosis of the disease because of its 
similarity to other septicemic diseases caused by gram –negative bacteria (Bullock, 1977, 
Actis et al., 2011). Diagnosis of the disease carried out using bacteriological examination 
(Actis et al., 2011). 
 
2.7.3. Control and prevention of the disease 
Good management practices such as maintenance of water quality, low stocking densities and 
good husbandry should be used to control vibriosis (Beacham and Evelyn, 1992, Samuelsen 
et al., 2006). In diseased fish, a successful treatment using antimicrobial is dependent on a 
rapid diagnosis and immediate treatment and Sulfamerazine and Oxytetracycline drugs can 
be used for the treatment of the disease(Actis et al., 2011). More over vaccination has proven 
to be an efficacious method in preventing vibriosis (Samuelsen et al., 2006) 
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3. Materials and methods 
3.1. Fish data 
The disease challenge test data of viral nervous necrosis and vibriosis used in this study were 
obtained from the National Atlantic cod breeding program which is running in Tromsø, 
Norway. The national Atlantic cod breeding program was started from 2002 and three 
parallel year-classes were formed as progeny of the wild-caught Atlantic cod. Details of the 
year- classes and mating design can be found in Bangera et al. (2011). In this study, we used 
disease challenge test data of year-class 2009 for both traits. The 2009 year–class data 
represent the second generation (F2) of the progeny of selected fish from year-class 2006 
(Bangera et al., 2011). 
 3.2. Data on disease challenge tests 
Disease resistance for viral nervous necrosis and vibriosis traits was measured as survival at a 
fixed point in time. It was also assessed as a binary variable where the observed value of each 
individual fish was 1 if the fish died following challenge test and 0 if it survived.  
3.2.1. Viral nervous necrosis challenge test data 
The challenge test was conducted using injection of a nodavirus suspension. The challenge 
test period was 35 days and the first mortality was set as a starting point. Preparation of the 
viral isolate, titration of virus and methods of the challenge test is presented in Ødegård et al. 
(2010). We obtained the result of this challenge test data of 707 individuals from 75 full-sib 
families and half-sib families (75 dams and 60 sires) of Atlantic cod. The number of 
individuals per family varied from 7 to 20 (average of 9.7). 
3.2.2. Vibriosis challenge test data 
728 individual challenge test results of vibriosis were obtained from The National cod 
breeding program. The duration of challenge test was 27 days like the other trait the first 
mortality was set as a starting point but it was conducted using bath challenge. More details 
about the challenge test protocol and fish population can be found in Kettunen et al. (2007). 
The individuals were from 75 full-sib families and half-sib families (75 dams and 57 sires) of 
Atlantic cod and the number of individuals per family varied from 6 to 10. 
3.3. Genotype data 
The Illumina Atlantic cod 12K SNP array were developed by the CSC (www.cigene.no) and 
used to genotype the Atlantic cod. Three genotype data sets were used in this study and based 
on these data sets three different genomic relation matrices were calculated. The first data set 
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contained 1,577 genotyped animals and the total pedigree of these animals contained 1,743 
entries. Genotype data on chromosome 8 (283 SNP markers) were used and the genotypes of 
the ungenotyped ancestors were imputed by LDMIP (Meuwissen and Goddard, 2010). We 
used this genotype data of 283 SNP markers to estimate the genomic relation matrix of the 
1,743 individuals at chromosome 8 (which we will call the SPARSE8). The second data set 
was 1,577 individuals genotyped data across the entire genome with Illumina Low-Density 
Atlantic cod SNP chip and based on this data set we calculated genomic relation matrix of 
1,577 individual using 8,658 SNP markers across the whole genome. This genomic relation 
matrix is called in this paper SPARSE GENOME. Low density genotypes data of 
chromosome 8 of 1,743 individuals’ were imputed up to sequence density (759,270 SNPs) 
genotypes the genome sequence (approx. 10X) of 111 sequenced parents of the challenge 
tested families (imputation by LDMIP).These imputed high density genotypes (759,270 
SNPs) were used to calculate the third genomic relation matrix (which we call the DENSE8). 
The genomic relation matrices were used in the GBLUP model to estimate the variance 
components which were explained by the genomic information and genomic breeding value. 
Details of the model and genomic relation matrix are presented in section 3.3.2. On top of the 
genotypes data, pedigree information of 1,743- individuals’ were used in the traditional 
BLUP and GBLUP with polygenic models. 
3.4. Statistical models 
Variances explained by the pedigree only, DENSE8 or SPARSE8 or SPARSE GENOME 
were estimated using ASReml software (Gilmour et al., 2009). These variance components 
estimates were used to calculate the heritabilities of the traits. We used two best linear 
unbiased prediction (BLUP) models for the estimation and prediction of the traditional 
breeding value and genomic breeding values. The first model was the traditional BLUP, 
while the second model was the GBLUP with a polygenic effect (using the pedigree based 
relationship matrix). Both models are presented below (Henderson, 1975, Meuwissen et al., 
2001).  
 
3.4.1. Traditional BLUP 
The traditional estimated breeding values and predicted values for both traits were 
determined using phenotypes and pedigree information based on the following model:  
                             y = 1μ + Za + e                                                                                  (5) 
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Where y is the vector of observed phenotypic values of individuals, μ is the overall mean, a is 
the vector of additive genetic effects of the phenotyped individuals and their parents, Z is the 
incidence matrix of a, and e is the vector of residual errors. The variance-covariance matrices 
of a and e are Aσa2 and Iσe2, respectively, where A is the additive genetic relationship matrix, 
σa2 is the additive genetic variance, and σe2 is the residual variance (Henderson, 1975). 
 
3.4.2. GBLUP with a polygenic effect 
The genomic breeding values using SPARSE8 or DENSE8 or SPARSE GENOME genomic 
relation matrices were estimated using GBLUP including the polygenic effect (Meuwissen et 
al., 2013, Meuwissen et al., 2001). In this paper GBLUP (SPARSE8), GBLUP (DENSE8) 
and GBLUP (SPARSE GENOME) model means a GBLUP model with polygenic effect and 
used the genomic relation matrix of SPARSE8, DENSE8 and SPARSE GENOME 
respectively. These models were also used to predict the genomic breeding values of masked 
individuals in the case of cross validation test (Meuwissen et al., 2013), and details of the 
cross validation test are presented in section 3.4. The model in matrix notation is presented 
below and y, 1n, and μ have the same definition as in equation 5  
                                 y = 1n u + Za+ Wg + e                                                                                  (6) 
 
Z= is the incidence matrix for the random polygenic effect 
a= is a vector containing a random polygenic effect for each individual 
 
a is assumed to follow N(0,Aσa2) where A is the pedigree based relationship matrix 
W=  is the incidence matrix for the random genomic effect 
g= vector of random additive genetic effect using the genomic relationship matrix (G) 
coming from (0, %σg2) 
e= vector of random residual errors (0, Iσe2) 
 
The genomic relationship matrix (G) was calculated by using SNP marker genotype 
according to VanRaden (2008) 
% = &&’/m 
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X= matrix of standardised SNP genotypes Xij 
m=number of SNPs 
Xij denotes the standardised SNP genotypes of animal i for SNP j 
 Genotypes values of the SNP are standardized to a mean of zero and a standard deviation of 
1 by subtracting the mean (2pj) and dividing by the standard deviation √H as presented below 
 
For genotypes 0, 1 and 2  
&() :(0 − 2) )/√*; (1−2) )/√*; (2 − 2) )/√* 
 
Where heterozygosity (H) = 2) (1 − )) and ) is the allele frequency of allele 1 and 0, 1, or 
2 are genotypes value for SNP with genotypes “0 0,” “0 1,” or “1 1,” respectively. Thus, the 
genomic relationships between two animals were calculated and the calculated genomic 
relationship matrix is implemented in the above equation to calculate GBLUP breeding 
values and the variance explained by the markers using ASReml (Gilmour et al., 2009). In 
order to test whether SPARSE8 explains more variance of the trait, i.e. whether chromosome 
8 explains more variance than other SNPs (disease resistance to viral nervous necrosis) than 
expected based on the SPARSE GENOME genomic relation matrix, we used the model 
GBLUP with polygenic effect by incorporating both SPARSE8 and SPARSE GENOME 
genomic relation matrices simultaneously by considering the covariance between the two 
genomic relation matrices. The model is presented below,  
                             y = 1n u + Za+ Wg +Qv+ e                                                                                    (7) 
 
Where y, u, Z, a W, g and e are similar like equation 6 and Q is a vector of genetic effect for a 
chromosome 8 assumed to be normally distributed with mean 0 and %σv2. 
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3.5. Cross validation test 
Within- and between-family cross validations were carried out in order to evaluate the 
accuracy of prediction for the viral nervous necrosis disease trait. The within-family cross 
validation will predict the accuracy of genomic breeding values under the assumption that the 
candidates have full-sibs with records. The between family cross validation will give the 
predicted accuracy under the assumption that phenotypic records come from more distant 
relatives. 
 
3.5.1. Within family cross validation 
 Fivefold within-family cross validation tests was carried out by randomly masking 20% of 
phenotypic records within each family. As a result of this, each observation within family 
were masked once and 141 phenotypes were masked in the first, second and third cross 
validation tests whereas 142 phenotypes were masked in the fourth and fifth cross validation 
tests. The phenotypic values of the masked individuals were predicted based on the 566 or 
565 (in the case of 142 individuals masked) phenotypic observations of the unmasked 
individuals. The accuracy of prediction was calculated based on the correlation between the 
predicted phenotypic values and observed phenotypic values. This correlation equals no more 
than the square root of the heritability of the trait, so we scaled the correlation result by the 
square root of the heritability to obtain an unbiased estimate of the accuracy of prediction 
from 5-fold cross validation (Meuwissen et al., 2013). 
 
3.5.2. Between family cross validation 
 Like the above procedure, fivefold between-family cross validation tests was carried out by 
randomly masking the phenotypic values of 20% of the families at a time, and their 
phenotypic values were predicted from the other families’ phenotypic values (Meuwissen et 
al., 2013). A total of 15 families were masked in each cross validation and the total masked 
phenotypes were 140, 142, 136, 137 and 153 in the first, second, third, fourth and fifth cross 
validation respectively. 
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4. Results 
4.1. The variance components 
The variance components explained by the traditional BLUP, GBLUP (SPARSE8), GBLUP 
(DENSE8) and SPARSE GENOME for both traits are presented in table 1 below. The 
correlation between the predicted values of the data (Yhat) of the model GBLUP (SPARSE8) 
and GBLUP (DENSE8) for the trait disease resistance to Viral nervous necrosis was high 
(figure 1).  
4.1.1 Viral nervous necrosis 
For the trait disease resistance to viral nervous necrosis, in the traditional BLUP model the 
pedigree information variance equal to 0.084 and the error variance was 0.15 (Table 1). 
When the data was analyzed using GBLUP(SPARSE8) or GBLUP(DENSE8) model the 
variance explained by SPARSE8 was a bit less than that of DENSE8 (Table1). Heritability 
estimates of the trait using the traditional BLUP and GBLUP (SPARSE8) were almost equal. 
However, GBLUP (DENSE8) and SPARSE GENOME had the lowest and the highest 
heritability estimates respectively (Table 1).  
When the disease challenge test results were analyzed using equation 7 by incorporating both 
SPARSE8 and SPARSE GENOME genomic relation matrices, 0.021, 0.047 and 0.017 of the 
variation were explained by SPARSE GENOME, PEDIGREE and SPARSE8 respectively 
and the error variance was 0.150. So, SPARSE8 explained 20% of the total genetic variance. 
The log-likelihood was 190 and not significantly better than same model without SPARSE8.  
4.1.2. Vibriosis 
The analysis of the disease challenge test result for the trait disease resistance to vibriosis is 
also presented in table 1.Using our data we were not able to distinguish between the genetic 
variation explained by the genomic information and the pedigree information. In the GBLUP 
(SPARSE8) and GBLUP (DENSE8) models the variance explained were estimated by fixing 
the variance explained by SPARSE8 and DENSE8 at the boundary of 0 respectively, 
however, in case of the SPARSE GENOME model, the PEDIGREE information was fixed at 
the boundary of 0.  Traditional BLUP, GBLUP (SPARSE8) and GBLUP (DENSE8) models 
gave similar heritability estimate but SPARSE GENOME heritability estimate was the 
highest. So, the heritability estimate was highest when the variance explained by the 
PEDIGREE information was fixed at the boundary of 0. (Table 1) 
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Figure 1. The correlation between the predicted values of the data (Yhat) of the model with 
SPARSE8 and DENSE8 for the trait viral nervous necrosis 
4.2. Evaluation of accuracies of prediction 
The correlation between the predicted phenotypic values and observed phenotypic values of 
the trait disease resistance to viral nervous necrosis for the different models are presented in 
table 2 and 3. The correlation results were scaled by dividing by the square root of the 
heritability (h2). 
4.2.1. Within-family cross-validation test 
Within–family cross validation test results for the trait disease resistance to viral nervous 
necrosis are presented in table 2. The traditional BLUP and GBLUP (DENSE8) models gave 
the same correlation (0.329), however the GBLUP (SPARSE8) gave higher correlation 
(0.334). The GENOME SPARSE model further improved the correlation (0.336). When the 
correlation was divided by h, GENOME SPARSE and SPARSE8 had the highest accuracy 
(0.56) (Table 2). 
4.2.2. Between-family cross-validation test 
The between-families correlations of the predicted phenotypic values and observed 
phenotypic values for the trait disease resistance to viral nervous necrosis are presented in 
table 3. The GBLUP (SPARSE8) had highest correlation (0.16) but the traditional BLUP had 
the least correlation (0.148). The comparison of within- and between- family accuracies of 
prediction for the trait disease resistance to viral nervous necrosis is presented in figure 2. In 
both case the DENSE8 had less accuracy of prediction than the SPARSE8.  
R² = 0,9617
0
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Table 1. The summary of the variance components of ASReml results for Viral nervous necrosis and Vibriosis 
 Traits  
 Viral nervous necrosis   Vibriosis   
Source of 
variance 
Traditional GBLUP GBLUP GBLUP  Traditional GBLUP GBLUP GBLUP 
 BLUP (SPARSE8) (DENSE8) SPARSE 
GENOME 
BLUP (SPARSE8) (DENSE8) SPARSE 
GENOME 
          
PEDIGREE1 0.084 0.075 0.06 0.066  0.009 0.009 0.009 0B 
SPARSE81 N 0.008 N N  N 0B N  
DENSE81 N N 0.018 N  N N 0B N 
SPARSE 
GENOME1 
N N N 0.02  N N N 0.019 
          
Error 0.15 0.151 0.155 0.146  0.152 0.152 0.152 0.144 
LogL.  189 190 189 190  304 304 304 302 
h2 0.359 0.355 0.335 0.371  0.056 0.056 0.056 0.117 
N = not part of the model                        1= genetic variance   B= fixed at a boundary 
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Table 2. The accuracies of prediction for the trait disease resistance to viral nervous necrosis for 
the within-family cross-validation test 
Models h2 Correlation  Accuracy 
Traditional BLUP 0.359 0.329 0.55 
GBLUP (SPARSE8) 0.355 0.334 0.56 
GBLUP (DENSE8) 0.335 0.329 0.55 
GBLUP (SPARSE 
GENOME) 
             0.371 0.336 0.56 
 
Table 3. The accuracies of prediction for the trait disease resistance to viral nervous necrosis for 
the between-family cross-validation test 
Models h2 Correlation Accuracy  
Traditional BLUP 0.359 0.148 0.25 
GBLUP (SPARSE8) 0.355 0.16 0.27 
GBLUP (DENSE8) 0.335 0.15 0.25 
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Figure 2. The comparison of within- and between- family accuracies of prediction for the trait 
disease resistance to viral nervous necrosis 
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5. Discussion 
The main objective of this study was to evaluate the accuracy of genomic prediction to disease 
resistance for viral nervous necrosis and vibriosis using sparse and genome sequence SNP-data 
in Atlantic cod. Several computer simulation studies showed that genomic selection can be used 
in aquaculture to use both within- and between-family variation during selection for both 
continuous and dichotomous (disease resistance) traits to increase the accuracy of selection 
(Nielsen et al., 2009, Sonesson and Meuwissen, 2009). However, our results did not show the 
significant role of genomic information in both traits.  
5.1. Viral nervous necrosis 
The heritability determines the strength of the relationship between phenotypes and genotypes is 
one of the most important factors that affects accuracy of selection and the success of genetic 
improvement of traits (Hedrick, 2011) . In this study the heritability of resistance to viral nervous 
necrosis in Atlantic cod had a slightly higher estimate in the case of the GBLUP (SPARSE 
GENOME) model, which was 0.371, than the traditional BLUP model, which was 0.359 (table 
1). But, for both models heritability estimates from our study to the trait were lower than the 
extremely high estimate of other studies in Atlantic cod. Using the 2007 year-class disease 
challenge test data of the National Atlantic cod breeding program, Ødegård et al. (2010) 
estimated the heritability of survival at the end of test to viral nervous necrosis, and the estimates 
were 0.75 and 0.43 using threshold mixed model and linear mixed model respectively. Another 
exceptionally high heritability (0.68) for viral nervous necrosis has been reported by Bangera et 
al. (2011) using 6185 individuals of the 2007 and 2009 year-classes disease challenge test data of 
the National Atlantic cod breeding program. In aquaculture, high heritability estimates to disease 
resistance have been reported in different studies, and among these Park and Casella (2008) 
reported heritability for resistance to three different diseases ranged between 0.42 and 0.57 in 
rainbow trout, and Hedrick (2011) also reported a high heritability of 0.26 on the observed scale 
and 0.55 on the underlying scale for infectious pancreatic necrosis (IPN) in Atlantic salmon. The 
total number of fish, the average number of fish per family, and the model we used in our study 
could be possible reasons for our relatively lower estimate of heritability for disease resistance to 
viral nervous necrosis. 
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In aquaculture, computer simulation studies showed high accuracy of selection based on the 
genomic information (Nielsen et al., 2009, Sonesson and Meuwissen, 2009). In addition to this, 
Lillehammer et al. (2013) also showed using a simulation study that a combination of genomic 
within-family breeding values based on low–density genotype and conventional BLUP family 
breeding values can be a possible low marker density implementation of genomic selection 
without compromising the effect of genomic selection on genetic gain for species with large full-
sib families. However in our study, based on within-family cross-validation tests, the accuracy of 
prediction of the genomic estimated breeding values using the sparse SNP markers (SPARSE 
GENOME) did not show a big difference compared with the traditional estimated breeding 
values. The accuracies of prediction were estimated as 0.336 and 0.329 in the SPARSE 
GENOME and traditional BLUP respectively (Table 2). A similar result was also reported by 
Mulder et al. (2012) in sheep for the trait concentration of omega 3 fatty acid compounds, and 
they found that the accuracy of the genomic estimated breeding values were very close to that of 
traditional estimated breeding values. Despite of a few reports that did not show higher accuracy 
of genomic estimated breeding values than the traditional estimate breeding values, the accuracy 
of the genomic estimated breeding value that can be achieved has been evaluated in different 
livestock species for a range of traits (Meuwissen et al., 2013), and genomic selection could 
overcome the shortcoming of the traditional selection method, whilst predicting the breeding 
values more accurately (Zhang et al., 2011, Meuwissen et al., 2001). In genomic estimated 
breeding values, increases in reliability varying between 20% and 29% were reported over those 
of the traditional selection for milk-yield traits in dairy cattle (Nielsen et al., 2009). In beef cattle 
the accuracy of genomic selection for growth and carcass traits were evaluated using cross-
validation, and up to 0.42 and 0.65 accuracies were reported for growth and carcass traits 
respectively (Nath et al., 2004). In pigs, for the trait feed conversion ratio, Meuwissen et al. 
(2001) reported that the genomic information gave more accurate genomic estimated breeding 
values than pedigree only estimated breeding values. In our study, the loss of the contribution of 
the genomic information to improve the accuracy of prediction over the traditional method could 
be due to the fact that phenotypical and genotypical data we used for training was too small to 
accurately capture the whole fraction of the variance explained by the SNP chip. SPARSE 
GENOME and SPARSE8 had almost similar accuracy of prediction (Table 2) that means the 
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SPARSE GENOME was not better than SPARSE8 and this could be due to within-family effects 
are hard to predict because of small family size (approximately 10).   
Using within-family cross-validation tests, we checked the accuracy of prediction of imputed 
high density genotypes (DENSE8) of chromosome 8 for disease resistance for viral nervous 
necrosis, but its accuracy of prediction was a bit less than that of SPARSE 8 (Figure 2). 
Generally, high density markers give more accurate prediction than low density markers or at 
least equal prediction (Solberg et al., 2008, Nielsen et al., 2009). This could be in within- family 
genomic selection, big segments are inherited together and the sparse SNPs could be sufficient to 
detect the chromosome segments. Further, we checked the accuracy of prediction of DENSE8 
using between-family cross-validation tests, since higher density markers are required for 
accurate prediction in the case of between-families, than for within-families (Meuwissen, 2009). 
But, in our result the DENSE8 resulted in lower accuracy of prediction than the SPARSE8. The 
lower accuracy of prediction of the DENSE8 than the SPARSE8 could be due to imputation 
errors compensating for the effect of a higher density. The SNP chip explain 24% of the variance  
from the total genetic variance (Table 1) and chromosome 8 (SPARSE8) explained 20% of 
genetic variance from the total genetic variance (result of equation 7). But, we did not get a 
similar finding using chromosome 8 (SPARSE8) and SPARSE GENOME for the trait disease 
resistance to vibrosis. The possible explanation for this could be due to differences in the genetic 
architecture and heritability of the traits. 
5.2. Vibriosis 
In this study using the traditional BLUP model, the heritability of disease resistance for vibriosis 
(which was measured as survival at a fixed point in time) was estimated to be low (0.059). Even 
though we were not able to distinguish the variances explained by the genomic information and 
pedigree information alone, the heritability estimate using GBLUP (SPARSE GENOME) was 
low but higher (0.117) than the traditional BLUP model. These low heritability estimates to 
disease resistance to vibriosis are in agreement with the results reported from other studies. 
Kettunen et al. (2007) reported low heritability estimates to disease resistance (measured as time 
at death) for vibriosis, which ranged from 0.08 to 0.17, depending upon the method used. Similar 
low heritability (0.16) to disease resistance (measured as survival at the end of test) to vibriosis 
were reported by Bangera et al. (2011). Another low heritability estimate (0.13) was reported for 
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disease caused by the bacteria Vibrio in other fish species (cold water vibriosis in Atlantic 
salmon) (Gjedrem and Gjøen, 1995). Moreover, very low heritability estimates of mortality and 
time of death for vibriosis in Chinook salmon was reported by Beacham and Evelyn (1992). It 
appears that the finding of low heritabilities for disease resistance for vibrosis is consistent across 
all studies.  
The low heritability estimate of disease resistance for vibriosis (which was measured as survival 
at a fixed point in time) in our study as well as others studies may not reflect the true additive 
genetic variation inherent in a population but rather a deficiency in the philosophy underpinning 
the models that are currently fitted (Lipschutz-Powell et al., 2012). Genetic analyses of 
resistance to infectious disease from disease data, which focus on individual’s susceptibility to 
infectious disease by ignoring the effect of its group members to the disease status of the 
individual tends to underestimate heritabilities estimate (Nath et al., 2004). Nath and his 
colleagues identified the impact that individuals have on each other as critical parameters for the 
risk and severity of infectious disease, and by taking into account the variation an individual’s 
impact on its group mates to severity of infectious disease; they improved the low heritabilities 
estimate (Nath et al., 2004). Moreover, the indirect genetic effects (IGE) model which considers 
the indirect genetic effect captures the inherent genetic variation an individual’s impact on its 
group mates to severity of infectious disease (Lipschutz-Powell et al., 2012). So, the low 
heritability estimate of disease resistance to vibriosis can be improved using the indirect genetic 
effects model and genomic information of large phenotypes and genotypes data (Ibañez-Escriche 
and Gonzalez-Recio, 2011, Lipschutz-Powell et al., 2012). 
A large number of phenotypes and genotypes are required for lower heritability traits than for 
higher heritability traits in order to get acceptable genomic accuracy (Ibañez-Escriche and 
Gonzalez-Recio, 2011). Due to this fact (and may be also due to the quality of the SNP chip), the 
genomic information (SPARSE GENOME) did not capture considerable amounts of the genetic 
variance. Since, we were not able to distinguish the genetic variance explained by the genomic 
and pedigree information, the accuracy of genomic prediction could not be assessed by cross-
validation. 
 
25 
 
6.  Conclusions 
In aquaculture industry genomic selection can be used to increase the accuracy of selection and 
to solve the lack of pedigree recording. Moreover, it has also a significant role to control 
inbreeding (Nielsen et al., 2009, Ibañez-Escriche and Gonzalez-Recio, 2011, Sonesson and 
Meuwissen, 2009). However, in our study, the accuracy of prediction using the genomic 
information (sparse markers) for disease resistance did not show a big difference compared to 
using only pedigree information for any of the traits and the traits showed different genetic 
architecture. In conclusion for both traits more phenotypic and genotypic data are required in 
order to properly evaluate the accuracy of prediction of the genomic information. But, disease 
resistance to vibriosis needs more phenotypic and genotypic data than viral nervous necrosis and 
this is due to the low heritability estimate of vibriosis (Ibañez-Escriche and Gonzalez-Recio, 
2011).  
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